These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24210736)

  • 1. Risk reducing mastectomy, breast reconstruction and patient satisfaction in Norwegian BRCA1/2 mutation carriers.
    Hagen AI; Mæhle L; Vedå N; Vetti HH; Stormorken A; Ludvigsen T; Guntvedt B; Isern AE; Schlichting E; Kleppe G; Bofin A; Gullestad HP; Møller P
    Breast; 2014 Feb; 23(1):38-43. PubMed ID: 24210736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior gluteal artery perforator flap in bilateral breast reconstruction.
    Werdin F; Peek A; Martin NC; Baumeister S
    Ann Plast Surg; 2010 Jan; 64(1):17-21. PubMed ID: 20010408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of prophylactic hysterectomy-oophorectomy, mastectomy, and microsurgical breast reconstruction in BRCA1 and BRCA2 carriers.
    Khansa I; Wang D; Coriddi M; Tiwari P
    Microsurgery; 2014 May; 34(4):271-6. PubMed ID: 24123194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of complications and patient satisfaction in pedicled transverse rectus abdominis myocutaneous and deep inferior epigastric perforator flap breast reconstruction.
    Momoh AO; Colakoglu S; Westvik TS; Curtis MS; Yueh JH; de Blacam C; Tobias AM; Lee BT
    Ann Plast Surg; 2012 Jul; 69(1):19-23. PubMed ID: 21659842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women.
    Bresser PJ; Seynaeve C; Van Gool AR; Brekelmans CT; Meijers-Heijboer H; van Geel AN; Menke-Pluijmers MB; Duivenvoorden HJ; Klijn JG; Tibben A
    Plast Reconstr Surg; 2006 May; 117(6):1675-82; discussion 1683-4. PubMed ID: 16651934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency and outcome of breast cancer risk-reducing surgery in Finnish BRCA1 and BRCA2 mutation carriers.
    Koskenvuo L; Svarvar C; Suominen S; Aittomäki K; Jahkola T
    Scand J Surg; 2014 Mar; 103(1):34-40. PubMed ID: 24177987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
    Friebel TM; Domchek SM; Neuhausen SL; Wagner T; Evans DG; Isaacs C; Garber JE; Daly MB; Eeles R; Matloff E; Tomlinson G; Lynch HT; Tung N; Blum JL; Weitzel J; Rubinstein WS; Ganz PA; Couch F; Rebbeck TR
    Clin Breast Cancer; 2007 Dec; 7(11):875-82. PubMed ID: 18269778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic.
    Heemskerk-Gerritsen BA; Brekelmans CT; Menke-Pluymers MB; van Geel AN; Tilanus-Linthorst MM; Bartels CC; Tan M; Meijers-Heijboer HE; Klijn JG; Seynaeve C
    Ann Surg Oncol; 2007 Dec; 14(12):3335-44. PubMed ID: 17541692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-reducing mastectomy in BRCA1/2 mutation carriers: factors influencing uptake and timing.
    van Driel CM; Eltahir Y; de Vries J; Jaspers JP; Oosterwijk JC; Mourits MJ; de Bock GH
    Maturitas; 2014 Feb; 77(2):180-4. PubMed ID: 24268650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Less correspondence between expectations before and cosmetic results after risk-reducing mastectomy in women who are mutation carriers: a prospective study.
    Brandberg Y; Arver B; Johansson H; Wickman M; Sandelin K; Liljegren A
    Eur J Surg Oncol; 2012 Jan; 38(1):38-43. PubMed ID: 22032910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
    Rebbeck TR; Friebel T; Lynch HT; Neuhausen SL; van 't Veer L; Garber JE; Evans GR; Narod SA; Isaacs C; Matloff E; Daly MB; Olopade OI; Weber BL
    J Clin Oncol; 2004 Mar; 22(6):1055-62. PubMed ID: 14981104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
    Isern AE; Tengrup I; Loman N; Olsson H; Ringberg A
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1177-87. PubMed ID: 17938010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).
    Kiely BE; Jenkins MA; McKinley JM; Friedlander ML; Weideman P; Milne RL; McLachlan SA; Hopper JL; Phillips KA
    Breast Cancer Res Treat; 2010 Apr; 120(3):715-23. PubMed ID: 19669874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers.
    Laitman Y; Vaisman Y; Feldman D; Helpman L; Gitly M; Paluch Shimon S; Berger R; Cohen L; Narod SA; Friedman E
    Clin Genet; 2014 Jan; 85(1):68-71. PubMed ID: 23517234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation Carriers.
    Fakkert IE; Mourits MJ; Jansen L; van der Kolk DM; Meijer K; Oosterwijk JC; van der Vegt B; Greuter MJ; de Bock GH
    Cancer Prev Res (Phila); 2012 Nov; 5(11):1291-7. PubMed ID: 23009828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature.
    Yao K; Liederbach E; Tang R; Lei L; Czechura T; Sisco M; Howard M; Hulick PJ; Weissman S; Winchester DJ; Coopey SB; Smith BL
    Ann Surg Oncol; 2015 Feb; 22(2):370-6. PubMed ID: 25023546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical prevention of breast carcinoma in patients with hereditary risk].
    Dražan L; Veselý J; Hýža P; Kubek T; Foretová L; Coufal O
    Klin Onkol; 2012; 25 Suppl():S78-83. PubMed ID: 22920212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
    Phillips KA; Jenkins MA; Lindeman GJ; McLachlan SA; McKinley JM; Weideman PC; Hopper JL; Friedlander ML;
    Clin Genet; 2006 Sep; 70(3):198-206. PubMed ID: 16922722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
    J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer.
    Kaas R; Verhoef S; Wesseling J; Rookus MA; Oldenburg HS; Peeters MJ; Rutgers EJ
    Ann Surg; 2010 Mar; 251(3):488-92. PubMed ID: 20134318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.